D-Wave Quantum reports second-quarter results on August 6. Revenue is estimated at roughly $4.02 million, up about 30% year over year. Options traders are pricing a move of about 13.5% in either direction, and the market has priced an earnings reaction of roughly ±10%.
A four-million-dollar revenue line producing a double-digit move in a multi-billion-dollar market capitalization tells you exactly what kind of security this is.
The numbers
| Metric | Reading |
|---|---|
| Earnings date | August 6, 2026 |
| Q2 revenue, estimated | ~$4.02M (+30% YoY) |
| EPS estimate | −$0.09 to −$0.12 |
| Implied move, options | ~±13.5% |
| Market-priced earnings reaction | ~±10.17% |
| Q1 2026 revenue | $2.9M |
| Q1 2026 bookings | $33.4M (~+1,994% YoY) |
| Remaining performance obligations | $42.4M |
| RPO expected to convert in 12 months | ~54% |
The only question that matters
Bookings of $33.4 million against quarterly revenue of $2.9 million. Remaining performance obligations of $42.4 million, of which roughly 54% is expected to be recognized within twelve months.
If that conversion happens, revenue moves from a rounding error to something like $20 million annualized within a year. That is still tiny, but it is a different category of tiny — it is the difference between a research organization and a company with customers who renew.
So the entire report reduces to one test: did bookings turn into recognized revenue this quarter, or did the backlog get bigger while the revenue line stayed flat?
A growing backlog with flat revenue is the pattern that has burned investors in every emerging-technology category. It means customers are willing to sign but not yet to deploy, and signatures that never convert are marketing, not business.
The part I'd be careful about
Almost everything, honestly, and I say that without hostility to the technology.
Quantum computing is a genuine field with genuine progress. It is also a field where the gap between capability demonstrations and commercial workloads remains wide, and where the timeline to broad utility has been consistently overestimated for fifteen years by people far more expert than the market.
The valuation is the acute issue. A multi-billion-dollar market capitalization against roughly $4 million of quarterly revenue means the price contains essentially no current business — it is entirely an option on a future one. That is a legitimate thing to buy if you size it as an option. It is a terrible thing to buy while telling yourself you own a technology company.
The implied 13.5% move is not a bug in the pricing, it is an accurate reflection of the fact that a single large contract or a single delayed deployment materially changes the story. When the revenue base is small enough, every quarter is a coin flip on lumpy enterprise deals.
My take
I don't own this and I don't short it. Shorting speculative technology on valuation is one of the most reliable ways to lose money, because the thing that ends these stories is a change in sentiment on a schedule nobody controls.
If someone wants exposure, the only defensible way I know is position sizing that assumes the outcome is zero. Not "assumes it might fall a lot" — assumes zero. Anything you'd be uncomfortable writing off entirely is too large a position in a company whose revenue would not cover the marketing budget of a mid-cap software firm.
What I'll actually read on August 6 is the RPO conversion line and nothing else. Revenue beating a $4 million estimate by half a million is noise. Backlog converting on schedule is signal, and it is the first real evidence that the commercial phase has started.
Bottom line: bookings up 1,994% against $2.9M of quarterly revenue. Either the backlog converts or it doesn't — and the price already assumes it does.
This is analysis, not investment advice.